Uncontrolled activation of the NF-κB signaling promotes chronic inflammation and autoimmune diseases such as inflammatory bowel disease, arthritis, and obesity (Cook et al., 2004; Marshak-Rothstein 2006; Simmonds and Foxwell 2008). This evidence concerns the gene NFKB1 and autoimmune disease.